169 related articles for article (PubMed ID: 38326404)
21. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
[TBL] [Abstract][Full Text] [Related]
22. Re-Irradiation with Intensity-Modulated Radiation Therapy for the Treatment of Recurrent Cervical Cancer in the Pelvis: An Analysis of Outcomes and Toxicity.
Kang HJ; Kwak YK; Lee SJ; Kim M
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374368
[No Abstract] [Full Text] [Related]
23. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
[TBL] [Abstract][Full Text] [Related]
24. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study.
Yamazaki H; Ogita M; Kodani N; Nakamura S; Inoue H; Himei K; Kotsuma T; Yoshida K; Yoshioka Y; Yamashita K; Udono H
Radiother Oncol; 2013 Jun; 107(3):305-9. PubMed ID: 23751378
[TBL] [Abstract][Full Text] [Related]
25. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
Lu H; Yao M; Tan H
Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
[TBL] [Abstract][Full Text] [Related]
26. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
[TBL] [Abstract][Full Text] [Related]
27. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
[TBL] [Abstract][Full Text] [Related]
28. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
29. Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
Ling DC; Vargo JA; Ferris RL; Ohr J; Clump DA; Yau WW; Duvvuri U; Kim S; Johnson JT; Bauman JE; Branstetter BF; Heron DE
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):973-980. PubMed ID: 27302512
[TBL] [Abstract][Full Text] [Related]
30. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
31. Re-irradiation in head and neck cancers: an Indian tertiary cancer centre experience.
Mallick S; Gandhi AK; Joshi NP; Pandit S; Bhasker S; Sharma A; Thakar A; Mohanti BK
J Laryngol Otol; 2014 Nov; 128(11):996-1002. PubMed ID: 25316005
[TBL] [Abstract][Full Text] [Related]
32. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
33. Clinical Impact of Re-irradiation with Carbon-ion Radiotherapy for Lymph Node Recurrence of Gynecological Cancers.
Shiba S; Okonogi N; Kato S; Wakatsuki M; Kobayashi D; Kiyohara H; Ohno T; Karasawa K; Nakano T; Kamada T
Anticancer Res; 2017 Oct; 37(10):5577-5583. PubMed ID: 28982873
[TBL] [Abstract][Full Text] [Related]
34. Organs at risk's tolerance and dose limits for head and neck cancer re-irradiation: A literature review.
Dionisi F; Fiorica F; D'Angelo E; Maddalo M; Giacomelli I; Tornari E; Rosca A; Vigo F; Romanello D; Cianchetti M; Tommasino F; Massaccesi M; Orlandi E
Oral Oncol; 2019 Nov; 98():35-47. PubMed ID: 31536844
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y
J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
[TBL] [Abstract][Full Text] [Related]
37. Local recurrence of breast cancer: conventionally fractionated partial external beam re-irradiation with curative intention.
Janssen S; Rades D; Meyer A; Fahlbusch FB; Wildfang I; Meier A; Schild S; Christiansen H; Henkenberens C
Strahlenther Onkol; 2018 Sep; 194(9):806-814. PubMed ID: 29796694
[TBL] [Abstract][Full Text] [Related]
38. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes.
Lewin R; Amit U; Laufer M; Berger R; Dotan Z; Domachevsky L; Davidson T; Portnoy O; Tsvang L; Ben-Ayun M; Weiss I; Symon Z
Radiat Oncol; 2021 Jun; 16(1):114. PubMed ID: 34162398
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
[TBL] [Abstract][Full Text] [Related]
40. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
